NEW YORK (GenomeWeb News) – Oligonucleotide synthesis startup Oligo Factor has opened a production facility in Holliston, Mass., the privately funded company said last week.
The company was founded in 2006 and specializes in "medium-scale" synthesis of DNA and RNA — on the order of tens of milligrams to multiple grams of oligos.
According to the company, the benefits of oligo synthesis on this scale are “predictably high quality, excellent yields, and low cost of manufacturing.”
Company co-founder Tim McGrath said in a statement that the company fills a niche between the “high-volume, micro-scale oligo synthesis companies” and the “the pharmaceutical-grade oligo synthesis houses.”